Literature DB >> 3274371

Elimination kinetics of cyclosporine following oral administration to children with renal transplants.

R Neiberger1, R Weiss, M Gomez, I Greifer, V A Tellis, A J Matas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3274371

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Improved cadaveric renal transplant outcome in children.

Authors:  R B Ettenger; J T Rosenthal; J L Marik; M Malekzadeh; S B Forsythe; E S Kamil; I B Salusky; R N Fine
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

2.  Higher plasma bilirubin predicts veno-occlusive disease in early childhood undergoing hematopoietic stem cell transplantation with cyclosporine.

Authors:  Kwi Suk Kim; Aree Moon; Hyoung Jin Kang; Hee Young Shin; Young Hee Choi; Hyang Sook Kim; Sang Geon Kim
Journal:  World J Transplant       Date:  2016-06-24

Review 3.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

4.  The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.

Authors:  J F Crocker; K W Renton; T L LeVatte; D H McLellan
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

5.  Triple immunosuppression with subsequent prednisolone withdrawal: 6 years' experience in paediatric renal allograft recipients.

Authors:  S M Chao; C L Jones; H R Powell; L Johnstone; D M Francis; G J Becker; R G Walker
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

6.  Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.

Authors:  E Jacqz-Aigrain; C Montes; P Brun; C Loirat
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 7.  Therapeutic drug monitoring of cyclosporin. Practical applications and limitations.

Authors:  V Rodighiero
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.